Tarrytown, New York, United States
Caitlin Knox, PhD MPH, Director Pharmacoepidemiology at Regeneron Pharmaceuticals, Inc. Dr. Knox evaluates drug safety of marketed products to deliver quality results and ensure an optimal safety profile. As the Pharmacoepidemiologic Therapeutic Lead within the Global Patient Safety organization, she regularly provides epidemiologic strategy to product teams and applies her epidemiologic expertise in the design and implementation of high profile observational studies, as well as lead the epidemiology requirements for regulatory documents, and lead several cross-functional teams that develop and implement Post-marketing Regulatory Commitment Studies globally.
Dr. Knox earned her PhD in Pharmaceutical Sciences-Pharmaceutical Outcomes and Policy with a concentration in Pharmacoepidemiology, as well as her Master of Public Health with a concentration in epidemiology and at the University of Florida. Dr. Knox has authored and co-authored several peer-reviewed publications and presented her research at national and international conferences. Dr. Knox is an active member of the professional association ISPE, were she is the current chair of the Education Committee, and past-chairs of the Membership Committee and Student Council.